A randomized comparative trial of continued abacavir/lamivudine plus efavirenz or replacement with efavirenz/emtricitabine/tenofovir DF in hypercholesterolemic HIV-1 infected individuals
about
Epidemiology and management of antiretroviral-associated cardiovascular disease.Comparative effectiveness of tenofovir in HIV-infected treatment-experienced patients: systematic review and meta-analysis.Modifying Antiretroviral Therapy in Virologically Suppressed HIV-1-Infected Patients.Risk of Cardiovascular Events Among Patients Initiating Efavirenz-Containing Versus Efavirenz-Free Antiretroviral RegimensRaltegravir in second-line antiretroviral therapy in resource-limited settings (SELECT): a randomised, phase 3, non-inferiority studyTenofovir disoproxil fumarate significantly decreases serum lipoprotein levels compared with entecavir nucleos(t)ide analogue therapy in chronic hepatitis B carriers.Clinical management of dyslipidaemia associated with combination antiretroviral therapy in HIV-infected patients.Switching antiretroviral regimes for the treatment of HIV: safety implications.Cardiovascular risk and dyslipidemia among persons living with HIV: a review.Effect of antiretroviral therapy use and adherence on the risk of hyperlipidemia among HIV-infected patients, in the highly active antiretroviral therapy era.Endocrinological aspects of HIV infection.Letter: lipid-lowering effect of tenofovir disoproxil fumarate in chronic hepatitis B-more evidence is needed.Evaluation of Oral Antiretroviral Drugs in Mice With Metabolic and Neurologic Complications
P2860
Q35338096-5102E50B-0C80-4E60-953A-1DF0933F159CQ36220644-F3B2A86F-85DC-46E3-93B2-56E3F9926599Q36426953-88A545BA-9304-4F6F-9927-8E6FD5D10FF2Q36899983-AA50EECD-92F6-4FCF-A3B5-9D465590E0A4Q37021431-5E847F42-16F0-424F-80C9-D050060CDA1FQ38679618-335C6ADF-15B7-472D-B316-C675BAB57942Q38723259-9BFCF7DC-023A-4235-914E-4D66254B69C6Q38879406-42C6222B-13F5-4F1D-A587-2B77CAEF5AE8Q40100018-E1E578A6-8DCB-4F68-B108-4A52B953EA23Q47112253-3C072C68-1D66-4F45-AEC7-54556DDC05EEQ47219853-E7A38672-F13E-479D-B540-B2120291781EQ48355843-615610FC-7290-4023-B9F6-3C38BB306B0EQ58764782-93308063-A807-4539-9A81-7CC582A1DEE0
P2860
A randomized comparative trial of continued abacavir/lamivudine plus efavirenz or replacement with efavirenz/emtricitabine/tenofovir DF in hypercholesterolemic HIV-1 infected individuals
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
A randomized comparative trial ...... mic HIV-1 infected individuals
@ast
A randomized comparative trial ...... mic HIV-1 infected individuals
@en
A randomized comparative trial ...... mic HIV-1 infected individuals
@nl
type
label
A randomized comparative trial ...... mic HIV-1 infected individuals
@ast
A randomized comparative trial ...... mic HIV-1 infected individuals
@en
A randomized comparative trial ...... mic HIV-1 infected individuals
@nl
prefLabel
A randomized comparative trial ...... mic HIV-1 infected individuals
@ast
A randomized comparative trial ...... mic HIV-1 infected individuals
@en
A randomized comparative trial ...... mic HIV-1 infected individuals
@nl
P2093
P2860
P3181
P1433
P1476
A randomized comparative trial ...... mic HIV-1 infected individuals
@en
P2093
Edmund Wilkins
Graeme J Moyle
Jacqueline Ewan
Jyoti Dhar
Martin Fisher
Ramin Ebrahimi
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0116297
P407
P577
2015-01-01T00:00:00Z